DR. SCHOLL'S ATHLETE'S FOOT SPRAY POWDER 1 %
TOLNAFTATE : 1 % · DIN 01919245 · SCHOLL'S WELLNESS COMPANY
Health Canada status: MARKETED
What is DR. SCHOLL'S ATHLETE'S FOOT SPRAY POWDER?
DR. SCHOLL'S ATHLETE'S FOOT SPRAY POWDER 1 % contains TOLNAFTATE : 1 %. It is listed in the Health Canada Drug Product Database under DIN 01919245, held by SCHOLL'S WELLNESS COMPANY, supplied as POWDER ; AEROSOL for TOPICAL administration. Health Canada currently lists it as marketed, status dated 10-Feb-2023. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 01919245 |
|---|---|
| Brand name | DR. SCHOLL'S ATHLETE'S FOOT SPRAY POWDER |
| Generic / active ingredient | TOLNAFTATE : 1 % |
| Manufacturer | SCHOLL'S WELLNESS COMPANY |
| Strength | 1 % |
| Dosage form | POWDER ; AEROSOL |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D01AE18 TOLNAFTATE |
| AHFS class | 84:04.08.40 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 10-Feb-2023 |
| Original market date | 1989-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code D01AE18 TOLNAFTATE. 11 of 52 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| FLEXITOL MEDICATED ANTI-FUNGAL CREAM | 1 % | CREAM | LACORIUM HEALTH INTERNATIONAL PTY LTD. | MARKETED | DIN 02295873 |
| FOOTRENEW | 1 % | SOLUTION | NAILRENEW CORP. | MARKETED | DIN 02527723 |
| FORMULA 3 | 1 % | SOLUTION | THE TETRA CORPORATION | MARKETED | DIN 02413760 |
| ODOR-EATERS | 1 % | AEROSOL | BLISTEX CORPORATION | MARKETED | DIN 02244777 |
| TINACTIN | 1 % | CREAM | BAYER INC | MARKETED | DIN 00576034 |
| TINACTIN AEROSOL POWDER | 1 % | POWDER ; AEROSOL | BAYER INC | MARKETED | DIN 00576050 |
| TINACTIN CHILL DEODORANT POWDER SPRAY | 1 % | AEROSOL ; POWDER | BAYER INC | MARKETED | DIN 02319276 |
| TINACTIN CHILL LIQUID SPRAY | 1 % | AEROSOL | BAYER INC | MARKETED | DIN 02319314 |
| TINACTIN POWDER | 1 % | POWDER | BAYER INC | MARKETED | DIN 00576042 |
| TOLNAFTATE CREAM USP, 1% | 1 % | CREAM | TARO PHARMACEUTICALS INC | MARKETED | DIN 02226707 |
Who else supplies TOLNAFTATE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. TOLNAFTATE appears in 663 registered pack listings across 2 markets, published on 2 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Request a quote for DR. SCHOLL'S ATHLETE'S FOOT SPRAY POWDER
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.